Skip to main content


Generic name: lidocaine hydrochloride ophthalmic gel
Drug class: Ophthalmic anesthetics
Approval date: October 7, 2008
Company: Akorn, Inc.
Treatment for: Ocular Anesthesia

Medically reviewed by Last updated on Aug 22, 2023.

What is Akten?

Akten Ophthalmic Gel 3.5% is a topical, ocular anesthetic formulation for use in any ocular procedure that requires a topical anesthetic agent, including cataract surgery, refractive surgery, Lasik surgery, and intravitreal injection.

Highlights of Akten Prescribing Information

Indications and Usage

Akten is a local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures.

Dosage and Administration

The recommended dose of Akten is 2 drops applied to the ocular surface in the area of the planned procedure. Additional anesthesia may be reapplied as needed.

Dosage Forms and Strengths

Akten 3.5% (35 mg/mL) Ophthalmic Gel

Warnings and Precautions

Adverse Reactions

Most common adverse reactions are conjunctival hyperemia, corneal epithelial changes, headache, and burning upon instillation.

To report SUSPECTED ADVERSE REACTIONS, contact FDA at 1-800-FDA-1088 or

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.